{"id":"W4400875117","doi":"10.1200/jco.23.02625","title":"Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dr. H. Bliss Murphy Cancer Centre; Kingston General Hospital; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Carboplatin; Pembrolizumab; Oncology; Paclitaxel; Head and neck; Internal medicine; Basal cell; Head and neck squamous-cell carcinoma; Phases of clinical research; Head and neck cancer; Chemotherapy; Radiation therapy; Surgery; Cancer; Immunotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002147518,0.00171622,0.001870414,0.0003386124,0.0003903271,0.001183946,0.001336159,0.00165896,0.005953473],"category_scores_gemma":[0.0009108046,0.0007093357,0.00140016,0.0003398918,0.001042399,0.001190162,0.0003862237,0.003240642,0.001291562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001041866,"about_ca_system_score_gemma":0.001945683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001082048,"about_ca_topic_score_gemma":0.003262722,"domain_scores_codex":[0.9995772,0.0001986547,0.00002244757,0.00007879242,0.00003240757,0.00009056817],"domain_scores_gemma":[0.999379,0.00008283135,0.000130231,0.00005612619,0.00004303574,0.0003087362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8731047,0.05043619,0.00124898,0.001421213,0.000838934,0.0001439207,0.0001531589,0.001171013,0.0181747,0.000276754,0.004091084,0.0489394],"study_design_scores_gemma":[0.8418302,0.1526248,0.002039544,0.00004807796,0.0003056428,0.0001087483,0.00003420401,0.0005611421,0.000972992,0.0001414491,0.001318099,0.00001507247],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9803419,0.004092536,0.0006966334,0.0007849127,0.0004017733,0.008100409,0.001784308,0.0002122809,0.003585166],"genre_scores_gemma":[0.9753054,0.003942105,0.002645464,0.002065471,0.0003674584,0.007271469,0.002542329,0.00003791106,0.005822284],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005953473,"threshold_uncertainty_score":0.0199163,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2017264981356598,"score_gpt":0.4899421537180798,"score_spread":0.2882156555824199,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}